PBPK.org - Interpretation of Biomonitoring Data Using PBPK Modeling @ The Hamner Institutes

Search News

Login

Syndicate

ATOM 0.3

OPML

Latest PBPK papers

Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data.
Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl cholinesterase inhibition.
Local Kinetics and Dynamics of Xenobiotics.
Windows((R)) based general PBPK/PD modeling software.
Improved predictive model for n-decane kinetics across species, as a component of hydrocarbon mixtures.
Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.
Using dietary exposure and physiologically based pharmacokinetic/pharmacodynamic modeling in human risk extrapolations for acrylamide toxicity.
Dynamic changes in lipids and proteins of maternal, fetal and pup blood and milk during perinatal development in CD and Wistar rats.
Quantitative interpretation of human biomonitoring data.
Approaches for applications of physiologically based pharmacokinetic models in risk assessment.

Interpretation of Biomonitoring Data Using PBPK Modeling @ The Hamner Institutes

PDF

Print

E-mail

Written by Martin Spendiff
Wednesday, 27 June 2007
Center for Human Health Assessment at The Hamner Institutes for Health Sciences will offer at one-day course on Interpretation of biomonitoring data using physiologically based pharmacokinetic (PBPK) modeling at The 17th Annual Conference of the International Society for Exposure Analysis. For more information go to http://secure.awma.org/events/ISEA/shortcourses.htm
Last Updated ( Wednesday, 27 June 2007 )

< Prev

: Sitemap : © Martin Spendiff 2008